Cinnamaldehyde decreases the invasion and u-PA expression of osteosarcoma by down-regulating the FAK signalling

Shu-Chen Chu1, Yih-Shou Hsieh2,3, Li-Sung Hsu4

  • 1Institute and Department of Food Science, Central Taiwan University of Science and Technology, Taichung, Taiwan.

Food & Function
|June 9, 2022
PubMed

Insights

Cinnamaldehyde, a natural compound, effectively inhibits osteosarcoma metastasis by reducing cell invasion and movement. This study shows its therapeutic potential against this deadly cancer complication.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Osteosarcoma metastasis significantly increases patient mortality.
  • Cinnamaldehyde exhibits anti-tumor properties, but its specific role in osteosarcoma metastasis requires further definition.

Purpose of the Study:

  • To investigate the antimetastatic effects of cinnamaldehyde on human osteosarcoma cells.
  • To elucidate the molecular mechanisms underlying cinnamaldehyde's action against osteosarcoma metastasis.

Main Methods:

  • In vitro and in vivo studies using Saos-2 and 143B human osteosarcoma cell lines.
  • Assessed urokinase-type plasminogen activator (u-PA) activity and protein levels.
  • Evaluated focal adhesion kinase (FAK) phosphorylation, cell migration, cell-matrix adhesion, and epithelial-to-mesenchymal transition (EMT) markers.

Main Results:

  • Cinnamaldehyde reduced u-PA activity and protein levels.
  • Inhibition of FAK phosphorylation suppressed osteosarcoma cell invasion.
  • Decreased cell movement, cell-matrix adhesion, and expression of fibronectin and N-cadherin.
  • Oral cinnamaldehyde administration significantly suppressed pulmonary metastasis in mice.

Conclusions:

  • Cinnamaldehyde demonstrates significant antimetastatic potential in osteosarcoma.
  • The compound inhibits key pathways involved in cancer cell invasion and metastasis.
  • Cinnamaldehyde represents a promising therapeutic agent for managing osteosarcoma metastasis.